Category Archives: McMaster University

Early stoppage of clinical trials

April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results

Posted in Cardiac surgery, FDA, McMaster University | Leave a comment

Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs

October 24, 2010- Gordon Guyatt, MD, epidemiologist, internist, and biostatistician at McMaster

Posted in Cardiology, FDA, McMaster University | Leave a comment

Gordon Guyatt, MD: on the problem of early stoppage of clinical trials

January 7, 2009- The ARBITER 6-HALTS study investigating Zetia and Niaspan was stopped

Posted in Cardiology, FDA, McMaster University | Leave a comment